GRAL vs LLY · rev $147.2M vs P/E 39, rev $22.97B
GRAIL, LLC (GRAL) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
GRAIL, LLC (GRAL) is a diagnostics & research company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
Latest reported GRAL revenue for 2025-12-31 was $147.2M. Net income was -$408.4M. Revenue was up 17.2% from 2024-12-31 to 2025-12-31. GRAL currently screens at market cap $2.57B.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
GRAL currently screens at market cap $2.57B. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the GRAL and LLY stock pages for the full models.
Not investment advice.